MedTrace Logo

Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome

NCT01945892 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2013-09-19

No results posted yet for this study

Summary

To analyze macula edema formation after cataract surgery called Irvine-Gass-Syndrome.

Conditions

  • Macular Edema
  • Visual Acuity

Interventions

DRUG

Ozurdex

\- Consent agreement - Patients should be informed that it is possible to get an active medication (Ozurdex implant) as an "on label" indication from the health insurance company if the diagnosis is accepted as an intraocular inflammation form of "Uveitis posterior".

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Wolfgang J Mayer, MD · LMU Munich

  • Christos Haritoglou, MD, PhD · LMU Munich

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-06-30
Completion
2013-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01945892 on ClinicalTrials.gov